282 related articles for article (PubMed ID: 34251422)
21. Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy.
Sevik MO; Aykut A; Çam F; Dericioğlu V; Şahin Ö
Ophthalmic Physiol Opt; 2023 Sep; 43(5):1203-1210. PubMed ID: 37318037
[TBL] [Abstract][Full Text] [Related]
22. The status of the choroid in patients with optic disc drusen.
Gediz BS; Erol YO; Gungor A; Ilhan B
Int Ophthalmol; 2022 Dec; 42(12):3891-3896. PubMed ID: 35788860
[TBL] [Abstract][Full Text] [Related]
23. Diurnal variation in subfoveal and peripapillary choroidal vascularity index in healthy eyes.
Singh SR; Rasheed MA; Goud A; Sahoo NK; Vupparaboina KK; Chhablani J
Indian J Ophthalmol; 2019 Oct; 67(10):1667-1672. PubMed ID: 31546505
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of choroidal blood flow parameters in optical coherence tomography and angiography in central serous chorioretinopathy.
Hwang BE; Kwak JH; Kim JY; Kim RY; Kim M; Park YG; Park YH
Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2111-2120. PubMed ID: 35201403
[TBL] [Abstract][Full Text] [Related]
25. Widefield Choroidal Thickness of Eyes with Central Serous Chorioretinopathy Examined by Swept-Source OCT.
Ishikura M; Muraoka Y; Nishigori N; Takahashi A; Miyake M; Ueda-Arakawa N; Miyata M; Ooto S; Tsujikawa A
Ophthalmol Retina; 2022 Oct; 6(10):949-956. PubMed ID: 35436598
[TBL] [Abstract][Full Text] [Related]
26. Abnormal choroidal flow on optical coherence tomography angiography in central serous chorioretinopathy.
Seo EJ; Um T; Yoon YH
Clin Exp Ophthalmol; 2019 May; 47(4):505-512. PubMed ID: 30515936
[TBL] [Abstract][Full Text] [Related]
27. Three-dimensional choroidal vascularity index and choroidal thickness in fellow eyes of acute and chronic primary angle-closure using swept-source optical coherence tomography.
Huang HL; Wang GH; Niu LL; Sun XH
Int J Ophthalmol; 2024; 17(1):42-52. PubMed ID: 38239961
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of the choroidal vascularity indexes in the fellow eyes of patients with pachychoroid neovasculopathy and central serous chorioretinopathy by binarization method.
Demirel S; Özcan G; Yanık Ö; Batıoğlu F; Özmert E
Graefes Arch Clin Exp Ophthalmol; 2020 Aug; 258(8):1649-1654. PubMed ID: 32415536
[TBL] [Abstract][Full Text] [Related]
29. Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study.
Iovino C; Au A; Chhablani J; Parameswarappa DC; Rasheed MA; Cennamo G; Cennamo G; Montorio D; Ho AC; Xu D; Querques G; Borrelli E; Sacconi R; Pichi F; Woodstock E; Sadda SR; Corradetti G; Boon CJF; van Dijk EHC; Loewenstein A; Zur D; Yoshimi S; Freund KB; Peiretti E; Sarraf D
Am J Ophthalmol; 2020 Sep; 217():104-113. PubMed ID: 32360342
[TBL] [Abstract][Full Text] [Related]
30. Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy.
Ambiya V; Yogi R; Li A; Shah S; Sarvaiya C; Mehta P; Meyerele C; Wu L; Singh R; Banker A; Chhablani J
Eye (Lond); 2016 Dec; 30(12):1623-1629. PubMed ID: 27689964
[TBL] [Abstract][Full Text] [Related]
31. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
32. En-face optical coherence tomography hyperreflective foci of choriocapillaris in central serous chorioretinopathy.
Hwang BE; Kim JY; Kim RY; Kim M; Park YG; Park YH
Sci Rep; 2023 May; 13(1):7184. PubMed ID: 37137948
[TBL] [Abstract][Full Text] [Related]
33. Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy.
Kwak JH; Hong SW; Ra H; Kim EC; Kang NY; Baek J
Korean J Ophthalmol; 2019 Dec; 33(6):493-499. PubMed ID: 31833245
[TBL] [Abstract][Full Text] [Related]
34. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
35. Association between central serous chorioretinopathy susceptibility genes and choroidal parameters.
Morino K; Miyake M; Kamei T; Kawaguchi T; Mori Y; Hosoda Y; Uji A; Yamashiro K; Matsuda F; Tsujikawa A
Jpn J Ophthalmol; 2022 Nov; 66(6):504-510. PubMed ID: 36181643
[TBL] [Abstract][Full Text] [Related]
36. CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: Assessment of Haller and Sattler Layers.
Chung YR; Kim JW; Kim SW; Lee K
Retina; 2016 Sep; 36(9):1652-7. PubMed ID: 26934451
[TBL] [Abstract][Full Text] [Related]
37. Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.
Okamoto M; Matsuura T; Ogata N
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):25-32. PubMed ID: 25559505
[TBL] [Abstract][Full Text] [Related]
38. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy.
Yun C; Huh J; Ahn SM; Lee B; Kim JT; Hwang SY; Kim SW; Oh J
Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):57-70. PubMed ID: 30397792
[TBL] [Abstract][Full Text] [Related]
39. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
Baek J; Lee JH; Jung BJ; Kook L; Lee WK
Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
[TBL] [Abstract][Full Text] [Related]
40. Comparing effects of photodynamic therapy in central serous chorioretinopathy: full-dose versus half-dose versus half-dose-half-fluence.
Park W; Kim M; Kim RY; Park YH
Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2155-2161. PubMed ID: 31367848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
